selected scholarly activity
-
chapters
- Nutritional Management of Inflammatory Bowel Disease. 355-383. 2023
- Nutritional Management of Inflammatory Bowel Disease. 333-356. 2017
- Nutritional Management of Inflammatory Bowel Disease. 295-312. 2013
- Nutritional Therapy. 337-350. 2008
-
conferences
- ASSESSING DISEASE SEVERITY IN PEDIATRIC IBD PATIENTS USING FECAL CALPROTECTIN AND MACHINE LEARNING. Gastroenterology. S1161-S1161. 2024
- FECAL CALPROTECTIN LEVEL DOES NOT CORRELATE WITH DISEASE LOCATION AT DIAGNOSIS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE. Gastroenterology. S1211-S1211. 2024
- VALIDATION OF THE USE OF ARTIFICIAL INTELLIGENCE FOR CLASSIFICATION OF ULCERATIVE COLITIS VS CROHN'S DISEASE IN PEDIATRIC PATIENTS. Gastroenterology. S1161-S1161. 2024
- A262 NEONATAL ACUTE LIVER FAILURE DUE TO PRESUMED GESTATIONAL ALLOIMMUNE LIVER DISEASE - A CASE REPORT. Journal of the Canadian Association of Gastroenterology. 81-82. 2023
- Systematic review with meta‐analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease. Alimentary Pharmacology and Therapeutics. 645-656. 2017
- Effectiveness of Targeted Food Elimination Diet in Management of Pediatric Eosinophilic Esophagitis (EoE): A Retrospective Review.. Journal of Allergy and Clinical Immunology. AB49-AB49. 2017
- Sa2070 A Qualitative Analysis of Barriers and Facilitators to an Effective Bowel Preparation for Colonoscopy in Children. Gastrointestinal Endoscopy. AB306-AB306. 2016
- Infliximab-Induced Psoriasis in Pediatric Crohn Disease; Experience of This Paradoxical Skin Manifestation At a Tertiary Centre and a Potential Association with a Variation in the IL-23r Gene. Gastroenterology. A671-A671. 2009
- Infliximab-induced psoriasis in pediatric Crohn Disease; Experience of this paradoxical event at a tertiary centre. Inflammatory Bowel Diseases. S23-S23. 2008
- Life threatening complications of sulphasalazine therapy in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases. S21-S21. 2008
- Discontinuation of immunomodulator therapy in infliximab-treated children with Crohn disease; one year outcome evaluating influences on disease activity and infliximab antibody formation. Inflammatory Bowel Diseases. S26-S26. 2008
- The development of a valid, reliable and responsive pediatric ulcerative colitis activity index (Pucai): A prospective multicenter study. Gastroenterology. A132-A132. 2007
-
journal articles
- Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases. 30:2418-2427. 2024
- Response from the Canadian Children Inflammatory Bowel Disease Network to the US Food and Drug Administration Draft Guidance for Industry on pediatric inflammatory bowel disease: developing drugs for treatment.. Journal of the Canadian Association of Gastroenterology. 7:397-398. 2024
- Additional published study for the scoping review on venous thromboembolism in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 78:1202-1202. 2024
- Physical Activity in Pediatric Inflammatory Bowel Disease: A Scoping Review. Pediatric Exercise Science. 36:44-56. 2024
- Microbiota signatures and mucosal healing in the use of enteral nutrition therapy v. corticosteroids for the treatment of children with Crohn’s disease: a systematic review and meta-analysis. British Journal of Nutrition. 130:1385-1402. 2023
- A262 NEONATAL ACUTE LIVER FAILURE DUE TO PRESUMED GESTATIONAL ALLOIMMUNE LIVER DISEASE - A CASE REPORT. Journal of the Canadian Association of Gastroenterology. 6:81-82. 2023
- Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada. Blood Coagulation and Fibrinolysis. 33:449-456. 2022
- Pediatric Patients With a Dual Diagnosis of Inflammatory Bowel Disease and Chronic Recurrent Multifocal Osteomyelitis. Journal of Pediatric Gastroenterology and Nutrition. 74:e129. 2022
- A66 THE IMPACT OF A MULTIDISCIPLINARY ADOLESCENT AND YOUNG ADULT (AYA) INFLAMMATORY BOWEL DISEASE (IBD) ON CLINIC NO SHOW RATES. Journal of the Canadian Association of Gastroenterology. 5:76-77. 2022
- A66 THE IMPACT OF A MULTIDISCIPLINARY ADOLESCENT AND YOUNG ADULT (AYA) INFLAMMATORY BOWEL DISEASE (IBD) ON CLINIC NO SHOW RATES. Journal of the Canadian Association of Gastroenterology. 5:76-77. 2022
- Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease. Nutrients. 14:4-4. 2021
- Pediatric Patients with a Dual Diagnosis of Inflammatory Bowel Disease and Chronic Recurrent Multifocal Osteomyelitis. Journal of Pediatric Gastroenterology and Nutrition. 73:626-629. 2021
- Clinical and Laboratory Characteristics Are Associated With Biologic Therapy Use in Pediatric Inflammatory Bowel Disease: A Retrospective Cohort Study. Journal of the Canadian Association of Gastroenterology. 4:e92-e100. 2021
- Effect of Exclusive Enteral Nutrition and Corticosteroid Induction Therapy on the Gut Microbiota of Pediatric Patients with Inflammatory Bowel Disease. Nutrients. 12:1691-1691. 2020
- A173 RECOGNIZING RARE PRESENTATIONS OF POLYPOSIS SYNDROMES AND THEIR ASSOCIATED MALIGNANCIES IN PEDIATRIC PATIENTS. Journal of the Canadian Association of Gastroenterology. 3:38-39. 2020
- A173 RECOGNIZING RARE PRESENTATIONS OF POLYPOSIS SYNDROMES AND THEIR ASSOCIATED MALIGNANCIES IN PEDIATRIC PATIENTS. Journal of the Canadian Association of Gastroenterology. 3:38-39. 2020
- A152 D-LACTIC ACIDOSIS IN CHILDREN WITH SHORT BOWEL SYNDROME-A LITERATURE REVIEW AND REPORT OF TWO CASES. Journal of the Canadian Association of Gastroenterology. 2:301-302. 2019
- A152 D-LACTIC ACIDOSIS IN CHILDREN WITH SHORT BOWEL SYNDROME-A LITERATURE REVIEW AND REPORT OF TWO CASES. Journal of the Canadian Association of Gastroenterology. 2:301-302. 2019
- Barriers and Facilitators to a Good Bowel Preparation for Colonoscopy in Children. Journal of Pediatric Gastroenterology and Nutrition. 67:188-193. 2018
- Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews. 2018:CD000542. 2018
- A153 MEASURING QUALITY OF LIFE AND DISEASE ACTIVITY IN PEDIATRIC PATIENTS RECEIVING INDUCTION THERAPY OF EXCLUSIVE ENTERAL NUTRITION OR CORTICOSTEROIDS FOR ACTIVE INFLAMMATORY BOWEL DISEASE. Journal of the Canadian Association of Gastroenterology. 1:264-265. 2018
- A153 MEASURING QUALITY OF LIFE AND DISEASE ACTIVITY IN PEDIATRIC PATIENTS RECEIVING INDUCTION THERAPY OF EXCLUSIVE ENTERAL NUTRITION OR CORTICOSTEROIDS FOR ACTIVE INFLAMMATORY BOWEL DISEASE. Journal of the Canadian Association of Gastroenterology. 1:264-265. 2018
- Infliximab‐Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL‐23 Receptor Polymorphisms. Journal of Pediatric Gastroenterology and Nutrition. 56:512-518. 2013
- Determinants of quality of life in children with chronic somatic disease: pilot data from the GapS Questionnaire. Quality of Life Research. 22:339-349. 2013
- IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis. Inflammatory Bowel Diseases. 19:115-123. 2013
- Drug-induced esophageal injury with an occult vascular ring. Paediatrics and Child Health. 16:554-556. 2011
- Assessment of knowledge in adolescents with inflammatory bowel disease using a novel transition tool. Inflammatory Bowel Diseases. 17:1131-1137. 2011
- Vulvar Inflammation as the Only Clinical Manifestation of Crohn Disease in an 8-Year-Old Girl. Pediatrics. 125:e1518-e1522. 2010
- Author's response to “Depth of inflammation in Crohn's disease”. Nature Reviews Nephrology. 5:E3-E3. 2009
- Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn's disease. Nature Reviews Nephrology. 4:693-697. 2008
- Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study. Gastroenterology. 133:423-432. 2007
- Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews. CD000542. 2007
- Severe Colitis in Children. Journal of Pediatric Gastroenterology and Nutrition. 41:375-385. 2005
- Case 1: Abdominal pain with weight loss. Paediatrics and Child Health. 9:719-720. 2004
- Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease. Canadian Journal of Gastroenterology and Hepatology. 18:503-508. 2004
- Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews. 2009:CD003574. 2004
- Gastral Antral Biopsy in the Differentiation of Pediatric Colitides. American Journal of Gastroenterology. 98:557-561. 2003
- Gastral antral biopsy in the differentiation of pediatric colitides. American Journal of Gastroenterology. 98:557-561. 2003
- Pediatric Crohn Disease Activity Index: Responsive to Short-term Change. Journal of Pediatric Gastroenterology and Nutrition. 36:83-89. 2003
- Controlled Ileal Release Budesonide in Pediatric Crohn Disease: Efficacy and Effect on Growth. Journal of Pediatric Gastroenterology and Nutrition. 33:75-80. 2001
- Enteral feeding and Crohn disease. Current Opinion in Gastroenterology. 17:167-170. 2001
- Enteral nutritional therapy for induction of remission in Crohn's disease. Clinical Respiratory Journal. CD000542. 2001
- Antineutrophil Cytoplasmic Antibodies and Anti-Saccharomyces cerevisiae Antibody: Clinical Tools or Clues for Research?. Journal of Pediatric Gastroenterology and Nutrition. 30:1-1. 2000
- Neurofibromatosis Type 1 Vasculopathy Associated With Lower Limb Hypoplasia. Pediatrics. 100:395-398. 1997